SEARCH

SEARCH BY CITATION

References

  • 1
    Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 11371141.
  • 2
    Nordin BEC, Roper A. Post pregnancy osteoporosis: A syndrome? Lancet 1955; 1: 431434.
  • 3
    Khovidhunkit W, Epstein S. Osteoporosis in pregnancy. Osteoporos Int 1996; 6: 345354.
  • 4
    O'Sullivan SM, Grey AB, Singh R, Reid IR. Biphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 2006; 17: 10081012.
  • 5
    Ofluoglu O, Ofluoglu D. A case report: Pregnancy- induced severe osteoporosis with eight vertebral fractures. Rheumatol Int 2008; 29: 197201.
  • 6
    Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol 1993; 39: 487490.
  • 7
    Holmberg-Marttila D, Sievanen H, Tuimala R. Changes in bone mineral density during pregnancy and postpartum: Prospective data on five women. Osteoporos Int 1999; 10: 4146.
  • 8
    Uemura H, Yasui T, Kiyokawa M et al. Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol 2002; 174: 353359.
  • 9
    Foster SA, Foley KA, Meadows ES et al. Characteristics of patients initiating teriparatide for the treatment of osteoporosis. Osteoporos Int 2008; 19: 373377.
  • 10
    Hellmeyer L, Kuhnert M, Ziller V, Schmidt S, Hadji P. The use i.v bisphosphonate in pregnancy-associated osteoporosis–case study. Exp Clin Endocrinol Diabetes 2007; 115: 139142.
  • 11
    Bayram S, Ozturk C, Sivrioglu K, Aydinli U, Kucukoglu S. Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint Bone Spine 2006; 73: 564566.
  • 12
    Patlas N, Colomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999; 60: 6873.
  • 13
    Lin JH, Duggan DE, Chen IWU, Ellsworth RL. Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals. Drug Metab Dispos 1991; 19: 926932.
  • 14
    Chesnut CH 3rd, Silverman S, Andriano K et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 2000; 109: 267276.
  • 15
    Muñoz-Torres M, Alonso G, Raya MP. Calcitonin therapy in osteoporosis. Treat Endocrinol 2004; 3: 117132.
  • 16
    Francis RM, Aspray TJ, Hide G, Sutcliffe AM, Wilkinson P. Back pain in osteoporotic vertebral fractures. Osteoporos Int 2007; 19: 895903.
  • 17
    Bennell KL, Matthews B, Greig A et al. Effects of an exercise and manual therapy program on physical impairments, function and quality-of-life in people with osteoporotic vertebral fracture: A randomised, single-blind controlled pilot trial. BMC Musculoskelet Disord 2010; 11: 36.
  • 18
    Dusdal K, Grundmanis J, Luttin K et al. Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: A systematic review. Osteoporos Int 2011; 22: 755769.
  • 19
    Boonen S, Wahl DA, Nauroy L et al. CSA Fracture Working Group of International Osteoporosis Foundation. Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures. Osteoporos Int 2011; 22: 29152934.